NAFLD is highly prevalent and thus understanding the impact of interventions on person-centred outcomes and costs is essential
The reasonable-physician position on this category: botanical glucose and metabolic wellness supplements occupy a legitimate but modest position in the evidence hierarchy
Back Sheridan, C (14 April 2025) 'Not just obesity: GLP-1 receptor agonists advance on addiction', Nature Biotechnology , 43, 455-47.Back Sims, EK, Carr, ALJ, Oram, RA, et al (15 July 2022) '100 years of insulin: celebrating the past, present and future of diabetes therapy', Nature Medicine , 27/7, 1154-64
Tissue and Cell Type Considerations Research across different tissue models has revealed some cell-type-specific differences in how IGF-1 DES and IGF-1 LR3 behave: Smooth muscle cells: IGF-1 DES has been studied in smooth muscle cell migration and proliferation models
Gastrointestinal (GI) issues The most frequently reported GLP-1 side effects impact the digestive system, especially during the first few weeks of therapy or after dose increases
Amino acids are the building blocks of protein, and people who eat high-protein diets probably ingest enough amino acid precursors to manufacture ample amounts of glutathione
